Important: Therapy
Trimethoprim oral 200mg 12 hourly (3 days)
or
Nitrofurantoin oral 50mg 6 hourly or 100mg MR 12 hourly (3 days)
We asked you in January to update to v4.7.2. After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.
To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number.
To update to the latest release:
On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.
On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.
Welcome to the February 2025 update from the RDS team
A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:
The release will also incorporate a number of small fixes, including:
We will let you know when the date and time for the new release are confirmed.
There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.
The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.
Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.
At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .
We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.
Some important toolkits in development by the RDS team include:
The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.
To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)
To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form - also available in End-user and Provider sections of the RDS Learning and Support area. If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.
With kind regards
Right Decision Service team
Healthcare Improvement Scotland
See under infection type
Trimethoprim oral 200mg 12 hourly (3 days)
or
Nitrofurantoin oral 50mg 6 hourly or 100mg MR 12 hourly (3 days)
Trimethoprim oral 200mg 12 hourly (7 days)
or
Nitrofurantoin oral 50mg 6 hourly or 100mg MR 12 hourly (7 days)
Cefalexin oral 250mg 6 hourly (7 days)
Mid-stream urine sample must be taken. Always treat asymptomatic bacteriuria.
A post-treatment specimen should always be sent.
Initial treatment
Amoxicillin 1g IV 8 hourly
Plus
Gentamicin IV (Extended Interval Dosing as per guideline) Use Gentamicin Calculator. Max 3 days then review.
Second line
Ciprofloxacin oral 500mg 12 hourly. Consider giving initial dose as 400mg IV.
Adjust therapy on basis of culture results or discuss with microbiology.
Total duration (IV&oral) = 7 days then review
In catheterised patients, the bladder quickly becomes colonised. Microscopy and/or “dip-stick” testing is unhelpful as WBC, rbc, nitrate and protein may all be positive when the bladder is colonised.
Catheter urine samples should be sent for culture and sensitivities only if patient is febrile or systemically unwell and bladder is the likely source.
If possible, remove catheter. Treat only if systematically unwell. If treating, the catheter should be changed.
Amoxicillin 1g IV 8 hourly
Plus
Gentamicin IV (Extended Interval Dosing as per guideline) Use Gentamicin Calculator. Max 3 days then review.
Second line
Vancomycin IV (Dosing as per guideline. Use vancomycin calculator.
Plus
Gentamicin IV (Extended Interval Dosing as per guideline) Use Gentamicin Calculator. Max 3 days then review.
Adjust therapy on basis of culture results or discuss with microbiology.
Total duration (IV&oral) = 7 days then review
First choice
Gentamicin
Dose: 3 mg/kg (lean body weight) up to a maximum of 320 mg IV single dose
or
Second choice
Trimethoprim
Dose: 200mg orally single dose
First line: Ciprofloxacin oral 500mg 12 hourly (4-6 weeks)
or
Second line: Trimethoprim oral 200mg 12 hourly (4-6 weeks)
Acute Prostatitis requires immediate treatment.
Chronic Prostatitis requires investigation before antimicrobials are started; only 10% of cases are caused by infection
Whenever possible, a specimen of urine should be collected for culture and sensitivity testing before starting antibacterial therapy. The therapy should reflect current local antibacterial sensitivity patterns.
In general asymptomatic bacteriuria in the elderly should not be treated with antibiotics. “Dip-stick” results are only helpful in MSU.
Remember genital tract sites e.g. vagina, prostate, may give rise to WBC on specimen microscopy.
Please contact a Nephrologist immediately if a kidney transplant patient is found to have a urinary tract infection.
Nitrofurantoin is contraindicated in patients with an eGFR <45ml/min. A short course (3-7days) may be used with caution in certain patients with an eGFR of 30-44ml/min. Only prescribe to such patients to treat lower UTI with suspected/proven multidrug resistant pathogens when the benefits of nitrofurantoin are considered to outweigh the risks of side effects.
Trimethoprim should be used with caution in patients with eGFR less than 30mL/min/1.73m2, refer to BNF for dose adjustments in renal impairment.